Intracranial administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in recurrent glioblastoma (rGB): a multi-cohort adaptive phase I clinical trial
- Julia Katharina Schwarze (Speaker)
- Geens, W. (Contributor)
- Tijtgat, J. (Contributor)
- Awada, G. (Contributor)
- Anne-Marie Van Binst (Contributor)
- Everaert, H. (Contributor)
- Seynaeve, L. (Contributor)
- Michotte, A. (Contributor)
- Bruneau, M. (Contributor)
- I VAN RIET (Contributor)
- Tuyaerts, S. (Contributor)
- Duerinck, J. (Contributor)
- Neyns, B. (Contributor)
Activiteit: Talk or presentation at a conference